# Study of KW-0761 (Mogamulizumab) in Subjects With Previously Treated Peripheral T-cell Lymphoma (PTCL)

> **NCT01611142** · PHASE2 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 38 (actual)

## Conditions studied

- Peripheral T-Cell Lymphoma

## Interventions

- **BIOLOGICAL:** KW-0761 (mogamulizumab)

## Key facts

- **NCT ID:** NCT01611142
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2024-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01611142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01611142, "Study of KW-0761 (Mogamulizumab) in Subjects With Previously Treated Peripheral T-cell Lymphoma (PTCL)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01611142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*